FDA Issues New Label Warnings For Ortho-McNeil-Janssen Pharmaceuticals, Inc.'s Ultram and Ultracet to Include Risk Of Suicide, Potential For Overdose

RomeNewswire -- The Federal Drug Administration (FDA), in conjunction with Ortho-McNeil-Janssen, have notified healthcare professionals of changes to the Warnings section of the prescribing information for tramadol, a centrally acting synthetic opioid analgesic indicated for the management of moderate to moderately severe chronic pain.